Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Bristol-Myers Squibb Stories

2013-01-25 08:24:37

HONG KONG, Jan. 25, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Bristol Myers Squibb (NYSE:BMY), Focus Media (NASDAQ:FMCN), Coach (NYSE:COH), Dell (NASDAQ:DELL), Boston Scientific (NYSE:BSX), and Lowe's (NYSE:LOW). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...

Billions Saved With Generic HIV Medication
2013-01-15 18:45:18

Lee Rannals for redOrbit.com — Your Universe Online Replacing brand-name, antiretroviral drugs recommended for control of HIV infection with generic medications could save nearly $1 billion a year on health care costs in the US. This strategy of replacing the brand-name drugs with the soon-to-be-available generic drugs could also come with its risks, diminishing the efficacy of the HIV treatment. "The switch from branded to generic antiretrovirals would place us in the...

A Traffic Cop For Stopping Cancer Cells?
2013-01-15 05:53:23

Connie K. Ho for redOrbit.com — Your Universe Online Researchers from the Fox Chase Cancer Center recently discovered a novel method of improving cancer drugs, where they could block a specific pathway in the cell and provide an easier way for drugs to eliminate tumors. According to the American Cancer Society, cancer occurs when there is uncontrolled growth and expansion of abnormal cells. It is caused by external factors (such as chemicals, infectious organisms, radiation, and...

2013-01-10 08:28:47

HONG KONG, Jan. 10, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Las Vegas Sands (NYSE:LVS), KeyCorp (NYSE:KEY), Bristol Myers Squibb (NYSE:BMY), Chesapeake Energy (NYSE:CHK), Starbucks (NASDAQ:SBUX), and Marvell (NASDAQ:MRVL). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to...

2013-01-03 08:27:02

BURLINGTON, Mass., Jan. 3, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that, from 2011 to 2021, growth in the hepatitis B virus (HBV) drug market will be driven by continued uptake of oral nucleoside/nucleotide analogues, such as Bristol-Myers Squibb's Baraclude (entecavir) and Gilead's Viread. However, the entry of generic Baraclude in 2015 and 2016 in the United States and Europe,...

2013-01-02 08:25:54

HONG KONG, Jan. 2, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: Bristol Myers Squibb (NYSE:BMY), Dell (NASDAQ:DELL), Chesapeake Energy (NYSE:CHK), Procter & Gamble (NYSE:PG), Alpha Natural Resources (NYSE:ANR), and Altria Group (NYSE:MO). (Logo: http://photos.prnewswire.com/prnh/20121105/HK06856LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full...

2012-12-14 08:24:35

MOBILE, Ala., Dec. 14, 2012 /PRNewswire/ -- James M. Lyons, President and Chief Executive Officer of The SSI Group, Inc. (SSI), announced today that Brian Campbell and Tom Myers have accepted the positions of Senior Vice President of Sales and Chief Strategy Officer respectively. Both Campbell and Myers will maintain their executive roles with MedWorth, a wholly-owned SSI subsidiary. Campbell currently serves as the Director of Business Development for MedWorth and Myers serves as the...

2012-12-01 05:03:02

New research report “KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen” elaborated by FirstWord has been recently published by Market Publishers Ltd. The study says that the HCV market is expected to have the best growth opportunities over the coming decade in comparison with other Pharma markets. London, UK (PRWEB) November 30, 2012 At present, the hepatitis C (HCV) market is entering a new stage due to the emergence of treatment innovations. The HCV...

2012-11-05 08:32:54

BARCELONA, Spain, November 5, 2012 /PRNewswire/ -- Life Science Entrepreneurs S.L.U., a company dedicated to the early-stage development of high-risk/very high return ventures, announced today the conclusion of a first investment for an antiplatelet drug candidate code-named NmC. Private investors from Barcelona, Geneva and Basel, all active in medical applications of life sciences, have funded the assays to confirm the safety and efficacy of the cardiovascular drug NmC....

2012-10-25 07:36:53

VANCOUVER, Oct. 25, 2012 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and Equity Research for the following companies: EMC (NYSE:EMC), Intel (NASDAQ:INTC), Bristol Myers Squibb (NYSE:BMY), Du Pont (NYSE:DD), Norfolk Southern (NYSE:NSC), and Nabors (NYSE:NBR). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report Highlights: EMC...